In Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram "-" Pathogens Isolated in Russia
Clinical trial NCT04679610 · COMPLETED
Trial details
- NCT number
- NCT04679610
- Sponsor
- The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-01
- Primary completion
- 2020-04-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.